JPH07502053A - ポリマーの表面コーティング - Google Patents
ポリマーの表面コーティングInfo
- Publication number
- JPH07502053A JPH07502053A JP5502087A JP50208793A JPH07502053A JP H07502053 A JPH07502053 A JP H07502053A JP 5502087 A JP5502087 A JP 5502087A JP 50208793 A JP50208793 A JP 50208793A JP H07502053 A JPH07502053 A JP H07502053A
- Authority
- JP
- Japan
- Prior art keywords
- group
- groups
- alkyl
- formula
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 title claims description 244
- 238000000576 coating method Methods 0.000 title claims description 49
- 239000011248 coating agent Substances 0.000 title claims description 38
- 125000000217 alkyl group Chemical group 0.000 claims description 131
- 229910052739 hydrogen Inorganic materials 0.000 claims description 116
- 239000001257 hydrogen Substances 0.000 claims description 115
- 239000000178 monomer Substances 0.000 claims description 115
- 125000004432 carbon atom Chemical group C* 0.000 claims description 81
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 66
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 64
- -1 ether acids Chemical class 0.000 claims description 59
- 238000000034 method Methods 0.000 claims description 55
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 47
- 125000002947 alkylene group Chemical group 0.000 claims description 43
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 40
- 230000003993 interaction Effects 0.000 claims description 40
- 239000003085 diluting agent Substances 0.000 claims description 39
- 238000006243 chemical reaction Methods 0.000 claims description 38
- 229910052757 nitrogen Chemical group 0.000 claims description 38
- 150000001875 compounds Chemical class 0.000 claims description 33
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 claims description 28
- 229920001577 copolymer Polymers 0.000 claims description 25
- 125000001153 fluoro group Chemical group F* 0.000 claims description 23
- 125000003010 ionic group Chemical group 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 19
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 19
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 17
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 15
- 125000004429 atom Chemical group 0.000 claims description 15
- 229910052760 oxygen Inorganic materials 0.000 claims description 14
- 239000001301 oxygen Substances 0.000 claims description 14
- 239000003446 ligand Substances 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 11
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 claims description 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 11
- 238000004132 cross linking Methods 0.000 claims description 10
- 150000002500 ions Chemical class 0.000 claims description 10
- 238000006116 polymerization reaction Methods 0.000 claims description 10
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 claims description 7
- 150000001721 carbon Chemical group 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- 230000000379 polymerizing effect Effects 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 72
- 239000000243 solution Substances 0.000 description 67
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 62
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 54
- 239000000203 mixture Substances 0.000 description 48
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 42
- 102000004169 proteins and genes Human genes 0.000 description 34
- 108090000623 proteins and genes Proteins 0.000 description 34
- 150000002431 hydrogen Chemical group 0.000 description 33
- 238000001179 sorption measurement Methods 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 150000003839 salts Chemical class 0.000 description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- 239000000463 material Substances 0.000 description 27
- 239000008280 blood Substances 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 26
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 26
- 150000003254 radicals Chemical class 0.000 description 23
- 239000000523 sample Substances 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
- 229910052731 fluorine Inorganic materials 0.000 description 21
- 102100032752 C-reactive protein Human genes 0.000 description 19
- 108010074051 C-Reactive Protein Proteins 0.000 description 18
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical group [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 18
- 239000011737 fluorine Chemical group 0.000 description 18
- 230000009467 reduction Effects 0.000 description 17
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 230000010118 platelet activation Effects 0.000 description 15
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 14
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 13
- 230000005661 hydrophobic surface Effects 0.000 description 13
- 239000012528 membrane Substances 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 11
- 238000003556 assay Methods 0.000 description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 230000027455 binding Effects 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 9
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 9
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 9
- 238000004375 physisorption Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000005855 radiation Effects 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical class CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 8
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 125000000524 functional group Chemical group 0.000 description 8
- 238000003018 immunoassay Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 230000009102 absorption Effects 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 108010049003 Fibrinogen Proteins 0.000 description 6
- 102000008946 Fibrinogen Human genes 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 239000001273 butane Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 229940012952 fibrinogen Drugs 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 6
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical group C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 5
- 229910000831 Steel Inorganic materials 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 5
- 230000010933 acylation Effects 0.000 description 5
- 238000005917 acylation reaction Methods 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 239000010408 film Substances 0.000 description 5
- 229910052736 halogen Inorganic materials 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000010959 steel Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- DDKMFQGAZVMXQV-UHFFFAOYSA-N (3-chloro-2-hydroxypropyl) 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CCl DDKMFQGAZVMXQV-UHFFFAOYSA-N 0.000 description 4
- QLIBJPGWWSHWBF-UHFFFAOYSA-N 2-aminoethyl methacrylate Chemical compound CC(=C)C(=O)OCCN QLIBJPGWWSHWBF-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- 239000008777 Glycerylphosphorylcholine Substances 0.000 description 4
- 239000003570 air Substances 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000013060 biological fluid Substances 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 230000005660 hydrophilic surface Effects 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical group CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- 238000003828 vacuum filtration Methods 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000008065 acid anhydrides Chemical class 0.000 description 3
- 150000001336 alkenes Chemical class 0.000 description 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000007334 copolymerization reaction Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005530 etching Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000003615 platelet activation assay Methods 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 239000003505 polymerization initiator Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 229960002317 succinimide Drugs 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- YHHSONZFOIEMCP-UHFFFAOYSA-N 2-(trimethylazaniumyl)ethyl hydrogen phosphate Chemical compound C[N+](C)(C)CCOP(O)([O-])=O YHHSONZFOIEMCP-UHFFFAOYSA-N 0.000 description 2
- QMQCYMRBZCWBNI-UHFFFAOYSA-N 2-aminopropyl 2-methylprop-2-enoate Chemical compound CC(N)COC(=O)C(C)=C QMQCYMRBZCWBNI-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- IWTYTFSSTWXZFU-UHFFFAOYSA-N 3-chloroprop-1-enylbenzene Chemical compound ClCC=CC1=CC=CC=C1 IWTYTFSSTWXZFU-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000257465 Echinoidea Species 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- LLCSWKVOHICRDD-UHFFFAOYSA-N buta-1,3-diyne Chemical group C#CC#C LLCSWKVOHICRDD-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000003618 dip coating Methods 0.000 description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 229940106780 human fibrinogen Drugs 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000005395 methacrylic acid group Chemical group 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 239000007981 phosphate-citrate buffer Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229950004354 phosphorylcholine Drugs 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000000159 protein binding assay Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 150000003440 styrenes Chemical class 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 229940038773 trisodium citrate Drugs 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 125000002348 vinylic group Chemical group 0.000 description 2
- QRHNWXNIURNVES-JBABRTIHSA-N (5r,6s,7r,8r)-5,6,7,8,9-pentahydroxy-2-methylnon-1-ene-3,4-dione Chemical group CC(=C)C(=O)C(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO QRHNWXNIURNVES-JBABRTIHSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- FGXKQXGCJXOIAL-UHFFFAOYSA-N 1,2,3,4,5-pentafluoro-6-(2-phenylethenyl)benzene Chemical compound FC1=C(F)C(F)=C(F)C(F)=C1C=CC1=CC=CC=C1 FGXKQXGCJXOIAL-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- FSSPGSAQUIYDCN-UHFFFAOYSA-N 1,3-Propane sultone Chemical compound O=S1(=O)CCCO1 FSSPGSAQUIYDCN-UHFFFAOYSA-N 0.000 description 1
- UGDMYHVETQRVGB-UHFFFAOYSA-N 1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N=CSC2=C1 UGDMYHVETQRVGB-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- PVBLJPCMWKGTOH-UHFFFAOYSA-N 1-aminocyclohexan-1-ol Chemical compound NC1(O)CCCCC1 PVBLJPCMWKGTOH-UHFFFAOYSA-N 0.000 description 1
- WJNKJKGZKFOLOJ-UHFFFAOYSA-N 1-dodecyl-4-ethenylbenzene Chemical compound CCCCCCCCCCCCC1=CC=C(C=C)C=C1 WJNKJKGZKFOLOJ-UHFFFAOYSA-N 0.000 description 1
- HLRQDIVVLOCZPH-UHFFFAOYSA-N 1-ethenyl-4-octylbenzene Chemical compound CCCCCCCCC1=CC=C(C=C)C=C1 HLRQDIVVLOCZPH-UHFFFAOYSA-N 0.000 description 1
- 150000003990 18-crown-6 derivatives Chemical group 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- WCVOGSZTONGSQY-UHFFFAOYSA-N 2,4,6-trichloroanisole Chemical group COC1=C(Cl)C=C(Cl)C=C1Cl WCVOGSZTONGSQY-UHFFFAOYSA-N 0.000 description 1
- PRAMZQXXPOLCIY-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethanesulfonic acid Chemical compound CC(=C)C(=O)OCCS(O)(=O)=O PRAMZQXXPOLCIY-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- UENGBOCGGKLVJJ-UHFFFAOYSA-N 2-chloro-1-(2,4-difluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CCl)C(F)=C1 UENGBOCGGKLVJJ-UHFFFAOYSA-N 0.000 description 1
- NORSCOJMIBLOFM-UHFFFAOYSA-N 2-hydroxyethyl 2-methylprop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CC(=C)C(=O)OCCO NORSCOJMIBLOFM-UHFFFAOYSA-N 0.000 description 1
- IPGXHRDWHJEWBI-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate;4-hydroxy-2-methylidenebutanoic acid Chemical compound OCCOC(=O)C=C.OCCC(=C)C(O)=O IPGXHRDWHJEWBI-UHFFFAOYSA-N 0.000 description 1
- 125000004810 2-methylpropylene group Chemical group [H]C([H])([H])C([H])(C([H])([H])[*:2])C([H])([H])[*:1] 0.000 description 1
- LZKGFGLOQNSMBS-UHFFFAOYSA-N 4,5,6-trichlorotriazine Chemical compound ClC1=NN=NC(Cl)=C1Cl LZKGFGLOQNSMBS-UHFFFAOYSA-N 0.000 description 1
- IHDBZCJYSHDCKF-UHFFFAOYSA-N 4,6-dichlorotriazine Chemical compound ClC1=CC(Cl)=NN=N1 IHDBZCJYSHDCKF-UHFFFAOYSA-N 0.000 description 1
- MAGFQRLKWCCTQJ-UHFFFAOYSA-N 4-ethenylbenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(C=C)C=C1 MAGFQRLKWCCTQJ-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical group CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- PWXLUJKGTZLAAQ-UHFFFAOYSA-N 4-methylbenzenesulfonic acid;pyrrolidine-2,5-dione Chemical compound O=C1CCC(=O)N1.CC1=CC=C(S(O)(=O)=O)C=C1 PWXLUJKGTZLAAQ-UHFFFAOYSA-N 0.000 description 1
- NIXVAPHNPNMUIX-UHFFFAOYSA-N 6-amino-2-methylhex-2-enamide Chemical compound NC(=O)C(C)=CCCCN NIXVAPHNPNMUIX-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 101100515517 Arabidopsis thaliana XI-I gene Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- AKBVGTFAOSPZLX-UHFFFAOYSA-N C(C(=C)C)(=O)OCCC=1C(=NN=NC1Cl)Cl Chemical compound C(C(=C)C)(=O)OCCC=1C(=NN=NC1Cl)Cl AKBVGTFAOSPZLX-UHFFFAOYSA-N 0.000 description 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 101000869592 Daucus carota Major allergen Dau c 1 Proteins 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 102100025027 E3 ubiquitin-protein ligase TRIM69 Human genes 0.000 description 1
- 102100037245 EP300-interacting inhibitor of differentiation 2 Human genes 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000282816 Giraffa camelopardalis Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101000830203 Homo sapiens E3 ubiquitin-protein ligase TRIM69 Proteins 0.000 description 1
- 101000881675 Homo sapiens EP300-interacting inhibitor of differentiation 2 Proteins 0.000 description 1
- 101000650136 Homo sapiens WAS/WASL-interacting protein family member 3 Proteins 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 102000008212 P-Selectin Human genes 0.000 description 1
- 108010035766 P-Selectin Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 102100027539 WAS/WASL-interacting protein family member 3 Human genes 0.000 description 1
- IUHFWCGCSVTMPG-UHFFFAOYSA-N [C].[C] Chemical group [C].[C] IUHFWCGCSVTMPG-UHFFFAOYSA-N 0.000 description 1
- XORPFVDIGIRKGM-UHFFFAOYSA-N [K].CCCOC(=O)C(C)=C Chemical compound [K].CCCOC(=O)C(C)=C XORPFVDIGIRKGM-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000004419 alkynylene group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- UKFWSNCTAHXBQN-UHFFFAOYSA-N ammonium iodide Chemical compound [NH4+].[I-] UKFWSNCTAHXBQN-UHFFFAOYSA-N 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003633 blood substitute Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-O butylazanium Chemical compound CCCC[NH3+] HQABUPZFAYXKJW-UHFFFAOYSA-O 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000012986 chain transfer agent Substances 0.000 description 1
- 125000002603 chloroethyl group Chemical group [H]C([*])([H])C([H])([H])Cl 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- XWBDWHCCBGMXKG-UHFFFAOYSA-N ethanamine;hydron;chloride Chemical compound Cl.CCN XWBDWHCCBGMXKG-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- VYFGDMAXYITNFT-UHFFFAOYSA-N ethyl phosphate;trimethylazanium Chemical compound C[NH+](C)C.C[NH+](C)C.CCOP([O-])([O-])=O VYFGDMAXYITNFT-UHFFFAOYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 1
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 1
- 150000007928 imidazolide derivatives Chemical class 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 150000003951 lactams Chemical group 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229920005684 linear copolymer Polymers 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- SBUYBNIDQXQZSZ-UHFFFAOYSA-N p-aminophenylphosphocholine Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC1=CC=C(N)C=C1 SBUYBNIDQXQZSZ-UHFFFAOYSA-N 0.000 description 1
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 125000005496 phosphonium group Chemical group 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 108010049148 plastin Proteins 0.000 description 1
- 229930192033 plastin Natural products 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- PNOXUQIZPBURMT-UHFFFAOYSA-M potassium;3-(2-methylprop-2-enoyloxy)propane-1-sulfonate Chemical compound [K+].CC(=C)C(=O)OCCCS([O-])(=O)=O PNOXUQIZPBURMT-UHFFFAOYSA-M 0.000 description 1
- CUQOHAYJWVTKDE-UHFFFAOYSA-N potassium;butan-1-olate Chemical compound [K+].CCCC[O-] CUQOHAYJWVTKDE-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000000075 primary alcohol group Chemical group 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000012719 thermal polymerization Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- ZCUFMDLYAMJYST-UHFFFAOYSA-N thorium dioxide Chemical class O=[Th]=O ZCUFMDLYAMJYST-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F246/00—Copolymers in which the nature of only the monomers in minority is defined
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Paints Or Removers (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Eyeglasses (AREA)
- External Artificial Organs (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Dental Preparations (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
Abstract
Description
Claims (19)
- 1.永久的正電荷の中心をもつペンダント基およびポリマーをある表面に安定に 結合することができる他のペンダント基を有する、1または2以上のラジカル重 合可能なモノマーのポリマー。
- 2.永久的正電荷の中心が両性イオンの基である請求の範囲第1項記載のポリマ ー。
- 3.式: Y−B−X(I) 式中、 Bは必要に応じて過フッ化鎖までかつそれを含む1または2以上のフッ素原子を 含有する直鎖状もしくは分枝鎖状のアルキレン、オキサアルキレンまたはオリゴ −オキサアルキレン鎖であるか、あるいはXがBと永久的正電荷の中心の間に炭 素−炭素鎖を含有するか、あるいはYがBに結合した末端炭素原子を含有する場 合、原子価結合であり、Xは両性イオンの基であり、そして Yは ▲数式、化学式、表等があります▼または▲数式、化学式、表等があります▼か ら選択されるエチレン系不飽和の重合可能な基であり、式中、Rは水素またはC 1−C4アルキル基であり、Aは−O−または−NR1−であり、ここでR1は 水素またはC1−C4アルキルであるか、あるいはR1は−B−X−であり、こ こでBおよびXは上に定義した通りであり、そしてKは基−(CH2)pOC( O)−、−(CH2)pC(O)O−、−(CH2)pOC(O)O−、−(C H2)pNR2−、−(CH2)pNR2C(O)−、−(CH2)pC(O) NR2−、−(CH2)pNR2C(O)O−、−(CH2)pOC(O)NR 2−、−(CH2)pNR2C(O)NR2−(ここで基R2は同一であるか、 あるいは異なる)、−(CH2)pO−、−(CH2)pSO3−、または、必 要に応じてBと組み合わせて、原子価結合であり、そしてpは1〜12であり、 そしてR2は水素またはC1−C4アルキル基である、 の両性イオンの基をもつコモノマーの残基を含む、請求の範囲第2項記載のポリ マー。
- 4.式(1)のコモノマーにおいて、Xが式(IVB)▲数式、化学式、表等が あります▼(IVB)式中基R6は同一であるか、あるいは異なり、そして各々 は水素またはC1−C4アルキルであり、そしてdは2〜4である、の基、 式(IVC) ▲数式、化学式、表等があります▼(IVC)式中基R7は同一であるか、ある いは異なり、そして各々は水素またはC1−C4アルキルであり、そしてeは1 〜4である、の基、 式(IVD) ▲数式、化学式、表等があります▼(IVD)式中基R8は同一であるか、ある いは異なり、そして各々は水素またはC1−C4アルキルであり、R8aは水素 または基−C(O)B1R8bであり、ここでR8bは水素またはメチルであり 、B1は原子価結合または直鎖状もしくは分枝鎖状のアルキレン、オキサアルキ レンまたはオリゴーオキサアルキレンであり、そしてfは1〜4であり、そして Bが原子価結合以外である場合、zは1でありそしてBが原子価結合である場合 、zは0であり、Xが酸素または窒素原子に直接結合している場合かつそれ以外 はzは1である、 の基、 式(IVE) ▲数式、化学式、表等があります▼(IVE)式中基R9は同一であるか、ある いは異なり、そして各々は水素またはC1−C4アルキルであり、R9■は水素 または基−C(O)B1R9bであり、ここでR9bは水素またはメチルであり 、B2は原子価結合または直鎖状もしくは分枝鎖状のアルキレン、オキサアルキ レンまたはオリゴーオキサアルキレンであり、そしてgは1〜4であり、そして Bが原子価結合以外である場合、zは1でありそしてBが原子価結合である場合 、zは0であり、Xが酸素または窒素原子に直接結合している場合かつそれ以外 はzは1である、 の基、または 式(IVF) ▲数式、化学式、表等があります▼(IVF)式中基R10は同一であるか、あ るいは異なり、そして各々は水素またはC1−C4アルキルであり、R10■は 水素または基−C(O)B1R10bであり、ここでR10bは水素またはメチ ルであり、B3は原子価結合または直鎖状もしくは分枝鎖状のアルキレン、オキ サアルキレンまたはオリゴーオキサアルキレンであり、そしてhは1〜4であり 、そしてBが原子価結合以外である場合、zは1でありそしてBが原子価結合で ある場合、zは0であり、Xが酸素または窒素原子に直接結合している場合かつ それ以外はzは1である、 の基、 である、請求の範囲第3項記載のポリマー。
- 5.式(IVC)のコモノマーの残基からなる請求の範囲第4項記載のポリマー 。
- 6.(i)両性イオンの基を含有するラジカル重合可能なコモノマーとラジカル 重合可能な部分および6またはそれ以上の炭素原子のアルキル基(前記アルキル 基は必要に応じて1または2以上のエーテル酸素原子および必要に応じて1また は2以上の炭素−炭素の二重結合または三重結合を含有する)またはフルオロア ルキル基(前記フルオロアルキル基は必要に応じて1または2以上のエーテル酸 素原子および必要に応じて1または2以上の炭素−炭素の二重結合または三重結 合を含有する)またはシロキサン基を含有するラジカル重合可能なコモノマーと を共重合させるか、あるいは (ii)両性イオンの基および6またはそれ以上の炭素原子のアルキル基(前記 アルキル基は必要に応じて1または2以上のエーテル酸素原子を含有する)また はフルオロアルキル基(前記フルオロアルキル基は必要に応じて1または2以上 のエーテル酸素原子を含有する)またはシロキサン基を含有するラジカル重合可 能なモノマーを重合させる、ことによって得ることができる、請求の範囲第1〜 5項のいずれかに記載のポリマー。
- 7.両性イオンの基を含有するコモノマーと、一般式(VI)Y1−Q (VI ) 式中、 Y1は ▲数式、化学式、表等があります▼または▲数式、化学式、表等があります▼か ら選択されるエチレン系不飽和の重合可能な基であり、ここでR14は水素また はC1−C4アルキル基であり、A′は−O−または−NR15−であり、ここ でR15は水素またはC1−C4アルキルであるか、あるいはR15は基Qであ り、K1は基−(CH2)1OC(O)−、−(CH2)1C(O)O−、−( CH2)1OC(O)O−、−(CH2)1NR18−、−(CH2)1NR1 6C(O)−、−(CH2)1C(O)NRI6、−(CH2)1NR16C( O)O−、−(CH2)1OC(O)NR16−、−(CH2)1NR16C( O)NR16(ここで基R16は同一であるか、あるいは異なる)、−(CH2 )1O−、−(CH2)1SO3−、または原子価結合であり、そして1は1〜 12であり、そしてR16は水素またはC1−C4アルキル基であり、そして Qは (a)6またはそれ以上の炭素原子を含有し、置換されていないか、あるいは1 または2以上のフッ素原子により置換されておりそして必要に応じて1または2 以上の炭素−炭素の二重結合または三重結合を含有する直鎖状もしくは分枝鎖状 のアルキル、アルコキシアルキルまたは(オリゴーアルコキシ)アルキル鎖、ま たは(b)シロキサン基−(CR16a2)qq(SiR16b2)(OSiR 16b2)ppR16b、ここで各基R16aは同一であるか、あるいは異なり 、そして水素または1〜4個の炭素原子を有するアルキルであり、各基R16b は1〜4個の炭素原子を有するアルキルであり、qqは1〜6であり、そしてp pは0〜49である、 である、 のアルキル、フルオロアルキルまたはシロキサン基を含有するコモノマーとを共 重合させることによって得ることができる、請求の範囲第6項記載のポリマー。
- 8.式(IV)ののコモノマーにおいて、Qが6またはそれ以上の炭素原子を含 有し、置換されていないか、あるいは1または2以上のフッ素原子により置換さ れた直鎖状もしくは分枝鎖状のアルキル、アルコキシアルキルまたは(オリゴ− ℃)アルキル鎖である、請求の範囲第7項記載のポリマー。
- 9.(i)両性イオンの基を含有するラジカル重合可能なコモノマーと、ある表 面にポリマーを共有結合させることができる反応性基をもつラジカル重合可能な コモノマーとを共重合させるか、あるいは(ii)両性イオンの基およびポリマ ーをある表面に共有結合させることができる反応性基を含有するラジカル重合可 能なモノマーを重合させる、 により得ることができる、請求の範囲第1〜5項のいずれかに記載のポリマー。
- 10.両性イオンの基を含有するコモノマーと、一般式(IX)Y2−Q1(I X) 式中、 Y2は ▲数式、化学式、表等があります▼または▲数式、化学式、表等があります▼か ら選択されるエチレン系不飽和の重合可能な基であり、ここでR19は水素また はC1−C4アルキル基であり、K2は基−(CH2)qOC(O)−、−(C H2)qC(O)O−、−(CH2)qOC(O)O−、−(CH2)qNR2 0−、−(CH2)qNR20C(O)−、−(CH2)qC(O)NR20− 、−(CH2)qNR20C(O)O−、−(CH2)qOC(O)NR20− 、−(CH2),NR20C(O)NR20(ここで基R20は同一であるか、 あるいは異なる)、−(CH2)qO−、−(CH2)・SO3−、または原子 価結合であり、そしてqは1〜12であり、そしてR20は水素またはC1−C 4アルキル基であり、そして Q1は反応してある表面への共有結合を提供することができる反応性基である、 のある表面へ共有結合することができる反応性基を含有するコモノマーとを共重 合させることによって得ることができる、請求の範囲第9項記載のポリマー。
- 11.i)両性イオンの基を含有するラジカル重合可能なコモノマーと、ある表 面にイオンの相互作用により結合することができるイオンの基をもつラジカル重 合可能なコモノマーとを共重合させるか、あるいはii)両性イオンの基および ある表面にイオンの相互作用により結合することができるイオンの基を含有する ラジカル重合可能なモノマーを重合させる、 ことによって得ることができる、請求の範囲第1〜5項のいずれかに記載のポリ マー。
- 12.両性イオンの基を含有するコモノマーと、式(XII)Y2−B9−Q5 (XII) 式中、 Y2は ▲数式、化学式、表等があります▼または▲数式、化学式、表等があります▼か ら選択されるエチレン系不飽和の重合可能な基であり、ここでR28は水素また はC1−C4アルキル基であり、A′′は−O−または−NR27−であり、こ こでR27は水素またはC1−C4アルキルであるか、あるいはR27は−B9 −Q5であり、B9は原子価結合または直鎖状もしくは分枝鎖状のアルキレン、 オキサアルキレンまたはオリゴ−オキサアルキレン基であり、K3は基−(CH 2)xOC(O)−、−(CH2)xC(O)O−、−(CH2)xOC(O) O−、−(CH2)xNR28−、−(CH2)xNR28C(O)−、−(C H2)xC(O)NR28−、−(CH2)xNR28C(O)O−、−(CH 2)xOC(O)NR28−、−(CH2)xNR28C(O)(ここで基R2 8は同一であるか、あるいは異なる)、−(CH2)xO−、−(CH2)xS O3−、または原子価結合であり、そしてxは1〜12であり、そしてR28は 水素またはC1−C4アルキル基であり、そして Q5はイオンの相互作用によりある表面に結合することができるイオンの基であ る、 のある表面にイオンの相互作用により結合することができるイオンの基をもつコ モノマーとを共重合させることによって得ることができる、請求の範囲第11項 記載のポリマー。
- 13.(a)5:95〜80:20のモル比における両性イオンの基を含有する コモノマーの残基およびポリマーをある表面に結合させることができるアルキル 、フルオロアルキルまたはシロキサン基を含有するコモノマーの残基、 (b)5:95〜95:5のモル比における両性イオンの基を含有するコモノマ ーの残基および共有結合によりポリマーをある表面に結合させることができる反 応性基を含有するコモノマーの残基、または(c)5:95〜95:5のモル比 における両性イオンの基を含有するコモノマーの残基およびイオンの相互作用に よりポリマーをある表面に結合させることができるイオンの基を含有するコモノ マーの残基、および 必要に応じて5〜50モル%の希釈剤のコモノマーの残基および0.1〜20モ ル%の架橋可能なコモノマーの残基、ただし希釈剤のコモノマーおよび架橋可能 なコモノマーの残基の合計は50モル%を越えない、からなる請求の範囲第1〜 12項のいずれかに記載のポリマー。
- 14.反応性基の残基によりポリマーに結合されたリガンドを有する、請求の範 囲第9または10項記載のポリマー。
- 15.ある表面にコーティングしたとき、反応性基の残基によりポリマーに結合 したリガンドを有する、請求の範囲第1〜14項のいずれかに記載のポリマー。
- 16.(a)永久的正電荷の中心をもつ基を含有するラジカル重合可能なコモノ マー、ポリマーをある表面に安定に結合することができる基を含有するラジカル 重合可能なコモノマーおよび必要に応じて希釈剤コモノマーおよび/または架橋 可能なコモノマーを共重合させるか、あるいは (b)永久的正電荷の中心をもつ基およびポリマーをある表面に安定に結合する ことができる基を含有するラジカル重合可能なモノマーおよび必要に応じてさら にポリマーをある表面に安定に結合することができる基を含有するコモノマーお よび希釈剤のコモノマーおよび/または架橋可能なコモノマーを重合させる、 ことからなるポリマーを製造する方法。
- 17.(a)ある表面を請求の範囲第1〜13項のいずれかに記載のポリマーで コーティングし、ここで前記ポリマーのコーティングは追加の未反応の反応性基 を含み、必要に応じてリガンドを前記表面にこのような反応性基との反応により 結合させるか、あるいは(b)反応性基を含む請求の範囲第1〜13項のいずれ かに記載のポリマーにリガンドを反応性基との反応により結合させ、そして前記 表面をリガンドを有するポリマーでコーティングする、ことからなる表面を生物 適合性化する方法。
- 18.請求の範囲第1〜15項のいずれかに記載のポリマーのコーティングをそ の上にを有する表面からなる仕上げられた装置。
- 19.式: CH2=CR14−C(O)−A′−QQ(VIIA)▲数式、化学式、表等が あります▼(VIII A)式中、 R14は水素またはC1−C4アルキル基であり、A′は−O−または−NR1 5−であり、ここでR15は水素またはC1−C4アルキルであるか、あるいは R15は基Qであり、K1は基−(CH2)1OC(O)−、−(CH2)1C (O)0−、−(CH2)1OC(O)O−、−(CH2)1NR16−、−( CH2)1NR16C(O)−、−(CH2)1C(O)NR16−、−(CH 2)1NR16C(O)O−、−(CH2)1OC(O)NR16−、−(CH 2)1NR16C(O)(ここで基R16は同一であるか、あるいは異なる)、 −(CH2)1O−、−(CH2)1SO3−、または原子価結合であり、そし て1は1〜12であり、そしてR16は水素またはC1−C4アルキル基であり 、そして QQは6またはそれ以上の炭素原子および1または2つの炭素−炭素の三重結合 を含有するアルキニル基であり、ただしアセチレン系部分はA′またはK′に直 接結合している、 の化合物。
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919114619A GB9114619D0 (en) | 1991-07-05 | 1991-07-05 | Surface coatings |
| GB9114619.1 | 1991-07-05 | ||
| GB919117170A GB9117170D0 (en) | 1991-08-08 | 1991-08-08 | Polymeric surface coatings |
| GB9117170.2 | 1991-08-08 | ||
| GB929208970A GB9208970D0 (en) | 1992-04-24 | 1992-04-24 | Polymeric surface coatings |
| GB9208970.5 | 1992-04-24 | ||
| PCT/GB1992/001215 WO1993001221A1 (en) | 1991-07-05 | 1992-07-06 | Polymeric surface coatings |
Related Child Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP20868798A Division JP3190620B2 (ja) | 1991-07-05 | 1998-07-08 | 表面を生物および血液適合性にするために有用なポリマー |
| JP20708498A Division JP3315367B2 (ja) | 1991-07-05 | 1998-07-08 | 表面を生物および血液適合性にするために有用なポリマー |
| JP20870198A Division JP3233902B2 (ja) | 1991-07-05 | 1998-07-08 | コーテイング組成物 |
| JP34809899A Division JP3204956B2 (ja) | 1991-07-05 | 1999-12-07 | ポリマーの表面コーティング |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH07502053A true JPH07502053A (ja) | 1995-03-02 |
| JP3030086B2 JP3030086B2 (ja) | 2000-04-10 |
Family
ID=27265753
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5502087A Expired - Lifetime JP3030086B2 (ja) | 1991-07-05 | 1992-07-06 | ポリマーの表面コーティング |
| JP20868798A Expired - Fee Related JP3190620B2 (ja) | 1991-07-05 | 1998-07-08 | 表面を生物および血液適合性にするために有用なポリマー |
| JP20870198A Expired - Lifetime JP3233902B2 (ja) | 1991-07-05 | 1998-07-08 | コーテイング組成物 |
| JP20708498A Expired - Fee Related JP3315367B2 (ja) | 1991-07-05 | 1998-07-08 | 表面を生物および血液適合性にするために有用なポリマー |
| JP34809899A Expired - Fee Related JP3204956B2 (ja) | 1991-07-05 | 1999-12-07 | ポリマーの表面コーティング |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP20868798A Expired - Fee Related JP3190620B2 (ja) | 1991-07-05 | 1998-07-08 | 表面を生物および血液適合性にするために有用なポリマー |
| JP20870198A Expired - Lifetime JP3233902B2 (ja) | 1991-07-05 | 1998-07-08 | コーテイング組成物 |
| JP20708498A Expired - Fee Related JP3315367B2 (ja) | 1991-07-05 | 1998-07-08 | 表面を生物および血液適合性にするために有用なポリマー |
| JP34809899A Expired - Fee Related JP3204956B2 (ja) | 1991-07-05 | 1999-12-07 | ポリマーの表面コーティング |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5648442A (ja) |
| EP (1) | EP0593561B1 (ja) |
| JP (5) | JP3030086B2 (ja) |
| AT (1) | ATE190988T1 (ja) |
| AU (1) | AU666485B2 (ja) |
| CA (3) | CA2277953C (ja) |
| DE (1) | DE69230823T2 (ja) |
| DK (1) | DK0593561T3 (ja) |
| ES (1) | ES2144419T3 (ja) |
| RU (1) | RU2167886C2 (ja) |
| WO (1) | WO1993001221A1 (ja) |
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07268038A (ja) * | 1994-03-31 | 1995-10-17 | Nippon Oil & Fats Co Ltd | ホスホリルコリン基又はその誘導体基含有共重合体、その製造法及び抗血栓性材料 |
| JPH08333421A (ja) * | 1995-04-03 | 1996-12-17 | Nippon Oil & Fats Co Ltd | ホスホリルコリン基含有重合体水性溶液および製造方法 |
| JPH11166015A (ja) * | 1991-07-05 | 1999-06-22 | Biocompatibles Ltd | 表面を生物および血液適合性にするために有用なポリマー |
| JPH11322857A (ja) * | 1998-05-08 | 1999-11-26 | Nof Corp | 静電結合型高分子複合体および製造方法 |
| JP2000162556A (ja) * | 1998-09-21 | 2000-06-16 | Menicon Co Ltd | 眼用レンズ材料およびその製法 |
| JP2001504877A (ja) * | 1996-11-20 | 2001-04-10 | バイオコンパテイブルズ・リミテツド | 生体適合性の組成物 |
| JP2002520463A (ja) * | 1998-07-17 | 2002-07-09 | バイオコンパテイブルズ・リミテツド | コートされた成形ポリマー物品の提供方法 |
| JP2002524628A (ja) * | 1998-09-15 | 2002-08-06 | ノバルティス アクチエンゲゼルシャフト | ポリマー |
| JP2002530456A (ja) * | 1998-11-13 | 2002-09-17 | バイオコンパテイブルズ・リミテツド | 両性イオン性モノマー成分を含んでなるアニオン性−カチオン性ポリイオンコンプレックス |
| JP2003503157A (ja) * | 1999-05-27 | 2003-01-28 | バイオコンパテイブルズ・リミテツド | 局所的な薬剤送達 |
| JP2003506501A (ja) * | 1999-05-27 | 2003-02-18 | バイオコンパテイブルズ・リミテツド | ポリマー溶液 |
| JP2004500458A (ja) * | 2000-02-07 | 2004-01-08 | バイオコンパティブルズ ユーケー リミテッド | モノマー及びマクロマーとして有用なマイケル型反応からの化合物を含む両性イオン基 |
| JP2004196868A (ja) * | 2002-12-16 | 2004-07-15 | Nof Corp | ポリマーナノスフェア、その用途及び製造方法 |
| JP2006124714A (ja) * | 1992-09-29 | 2006-05-18 | Toray Ind Inc | 耐汚染性材料および耐汚染性半透膜 |
| WO2007116690A1 (ja) | 2006-03-29 | 2007-10-18 | Japan Medical Materials Corporation | 生体材料、及びそれを用いた人工関節並びにその製造方法 |
| JP2010024257A (ja) * | 2008-07-15 | 2010-02-04 | Fujifilm Corp | 生体適合性重合性化合物、生体適合性ポリマー、及び、ポリマー粒子 |
| US7713520B2 (en) | 2004-03-31 | 2010-05-11 | Shin-Etsu Chemical Co., Ltd. | Cosmetic comprising a silicone polymer |
| JP2013529118A (ja) * | 2010-05-25 | 2013-07-18 | スリーエム イノベイティブ プロパティズ カンパニー | 抗菌剤コーティングされた医療用物品 |
| JP2015084848A (ja) * | 2013-10-29 | 2015-05-07 | 株式会社八光 | 医療用樹脂成形物へのコーティング方法 |
| JP2015117269A (ja) * | 2013-12-17 | 2015-06-25 | 日油株式会社 | ポリマー及びその製造方法 |
| JP2016514750A (ja) * | 2013-03-25 | 2016-05-23 | ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピックSociete D’Exploitation De Produits Pour Les Industries Chimiques Seppic | 新規な両親媒性ポリマー及び疎水性材料から作られている表面の処理におけるその使用 |
| WO2016158700A1 (ja) * | 2015-03-30 | 2016-10-06 | テルモ株式会社 | 医療用具 |
| CN106794290A (zh) * | 2014-10-02 | 2017-05-31 | 旭化成医疗株式会社 | 源自生物体的液体处理过滤器及过滤器装置 |
| JP2017190381A (ja) * | 2016-04-12 | 2017-10-19 | 花王株式会社 | 表面処理剤 |
| JP2019210363A (ja) * | 2018-06-04 | 2019-12-12 | 信越化学工業株式会社 | ポリシロキサンモノマー及びその製造方法 |
| JP2020063318A (ja) * | 2018-10-15 | 2020-04-23 | 千秋 東 | ホスホリルコリン基含有共重合体、および生体用医療基材 |
| WO2021070862A1 (ja) * | 2019-10-09 | 2021-04-15 | 日油株式会社 | ソフトコンタクトレンズ用表面処理剤 |
Families Citing this family (141)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9023498D0 (en) * | 1990-10-29 | 1990-12-12 | Biocompatibles Ltd | Soft contact lens material |
| US6090901A (en) * | 1991-07-05 | 2000-07-18 | Biocompatibles Limited | Polymeric surface coatings |
| US6225431B1 (en) | 1991-07-05 | 2001-05-01 | Biocompatibles Limited | Biocompatibilizing process |
| AU728822C (en) * | 1991-07-05 | 2001-08-16 | Biocompatibles Uk Limited | Polymeric surface coatings |
| US6743878B2 (en) | 1991-07-05 | 2004-06-01 | Biocompatibles Uk Limited | Polymeric surface coatings |
| DE69231476T2 (de) * | 1991-07-05 | 2001-01-25 | Biocompatibles Ltd., Farnham | Polymere Oberflächenbeschichtungszusammensetzungen |
| ATE270310T1 (de) * | 1991-08-08 | 2004-07-15 | Biocompatibles Uk Ltd | Polymere oberflächenbeschichtungszusammensetzungen |
| GB9226791D0 (en) * | 1992-12-23 | 1993-02-17 | Biocompatibles Ltd | New materials |
| GB9301702D0 (en) * | 1993-01-28 | 1993-03-17 | Biocompatibles Ltd | New materials |
| GB9301701D0 (en) * | 1993-01-28 | 1993-03-17 | Biocompatibles Ltd | New zwitterionic materials |
| GB9317178D0 (en) * | 1993-08-18 | 1993-10-06 | Biocompatibles Ltd | Polymer surface coatings |
| GB9324033D0 (en) * | 1993-11-23 | 1994-01-12 | Biocompatibles Ltd | Ethylenically unsaturated compounds |
| GB9415926D0 (en) * | 1994-08-04 | 1994-09-28 | Biocompatibles Ltd | New materials |
| FR2717818B1 (fr) * | 1994-03-25 | 1996-06-07 | Rhone Poulenc Chimie | Latex à caractère zwitterionique. |
| EP0767212B1 (en) | 1995-04-03 | 2001-07-18 | Nof Corporation | Process for producing an aqueous solution of phosphorylcholine group bearing polymer and aqueous solution of phosphorylcholine group bearing polymer |
| DE69609568T2 (de) * | 1995-05-26 | 2001-02-01 | Sumitomo Electric Industries, Ltd. | Verfahren zur Herstellung von einem II-VI oder III-V Halbleitereinkristall |
| GB9522332D0 (en) | 1995-11-01 | 1996-01-03 | Biocompatibles Ltd | Braided stent |
| CA2192520A1 (en) | 1996-03-05 | 1997-09-05 | Ian M. Penn | Expandable stent and method for delivery of same |
| US6443942B2 (en) | 1996-11-01 | 2002-09-03 | Minimed, Inc. | Medication device with protein stabilizing surface coating |
| WO1998030615A1 (en) * | 1997-01-10 | 1998-07-16 | Biocompatibles Limited | Polymers |
| AU7781298A (en) * | 1997-06-04 | 1998-12-21 | Biocompatibles Limited | Phosphate compounds |
| EP0930357A1 (en) * | 1997-12-09 | 1999-07-21 | Biocompatibles Limited | Contact lens cleaning solutions |
| EP0928604A1 (en) | 1997-12-12 | 1999-07-14 | Biocompatibles Limited | Stent |
| US6258371B1 (en) * | 1998-04-03 | 2001-07-10 | Medtronic Inc | Method for making biocompatible medical article |
| US6346594B1 (en) * | 1998-09-21 | 2002-02-12 | Menicon Co., Ltd. | Ocular lens material and process for producing same |
| US6562330B1 (en) | 1998-11-13 | 2003-05-13 | Biocompatibles Limited | Therapeutic use of polymers |
| US6231422B1 (en) | 1999-05-21 | 2001-05-15 | Bong Kyu Choi | Toy automobile |
| EP1189553B1 (en) * | 1999-06-24 | 2004-03-31 | Abbott Vascular Devices Limited | Balloon expandable stent |
| US6436615B1 (en) * | 1999-06-25 | 2002-08-20 | The United States Of America As Represented By The Secretary Of The Navy | Methods and materials for selective modification of photopatterned polymer films |
| AU6000200A (en) | 1999-07-16 | 2001-02-05 | Biocompatibles Limited | Braided stent |
| ATE337805T1 (de) * | 1999-07-28 | 2006-09-15 | Nof Corp | Medizinische materialien und verfahren zu deren herstellung |
| US6746686B2 (en) | 2000-01-24 | 2004-06-08 | Biocompatibles Uk Limited | Coated implants |
| EP1255761B1 (en) | 2000-02-07 | 2005-08-31 | Biocompatibles UK Limited | Silicon containing compounds from michael - type addition reactions useful as monomers and macromers |
| US6533415B2 (en) * | 2000-03-21 | 2003-03-18 | Menicon Co., Ltd. | Ocular lens material having hydrophilic surface and process for preparing the same |
| JP2001337298A (ja) * | 2000-03-21 | 2001-12-07 | Menicon Co Ltd | 親水性表面を有する眼用レンズ材料およびその製法 |
| AU2001292092A1 (en) | 2000-10-06 | 2002-04-15 | Biocompatibles Uk Limited | Zwitterionic polymers |
| AU2002214160A1 (en) * | 2000-11-16 | 2002-05-27 | Biocompatibles Uk Limited | Polymers and polymerisation processes |
| GB0100760D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| JP4738663B2 (ja) * | 2001-08-07 | 2011-08-03 | 株式会社メニコン | 眼科用物品の製造方法並びに製造装置 |
| US20030225451A1 (en) * | 2002-01-14 | 2003-12-04 | Rangarajan Sundar | Stent delivery system, device, and method for coating |
| ATE405594T1 (de) * | 2002-01-15 | 2008-09-15 | Advanced Elastomer Systems | Thermoplastische elastomere |
| WO2003062290A1 (en) * | 2002-01-16 | 2003-07-31 | Biocompatibles Uk Limited | Polymer conjugates |
| US20070227907A1 (en) * | 2006-04-04 | 2007-10-04 | Rajiv Shah | Methods and materials for controlling the electrochemistry of analyte sensors |
| US7813780B2 (en) * | 2005-12-13 | 2010-10-12 | Medtronic Minimed, Inc. | Biosensors and methods for making and using them |
| US9492111B2 (en) * | 2002-04-22 | 2016-11-15 | Medtronic Minimed, Inc. | Methods and materials for stabilizing analyte sensors |
| US20040056371A1 (en) * | 2002-09-25 | 2004-03-25 | Medennium, Inc. | Method of manufacturing ophthalmic lenses made from hydrophobic acrylic polymers |
| JP3975880B2 (ja) * | 2002-10-17 | 2007-09-12 | 日本油脂株式会社 | 表面被覆処理された粉体を含有してなる化粧料 |
| US20050272989A1 (en) * | 2004-06-04 | 2005-12-08 | Medtronic Minimed, Inc. | Analyte sensors and methods for making and using them |
| US9237865B2 (en) * | 2002-10-18 | 2016-01-19 | Medtronic Minimed, Inc. | Analyte sensors and methods for making and using them |
| US20040074785A1 (en) * | 2002-10-18 | 2004-04-22 | Holker James D. | Analyte sensors and methods for making them |
| JP2006508744A (ja) * | 2002-12-04 | 2006-03-16 | レイク リージョン マニュファクチュアリング インコーポレイテッド | 標識付きガイドワイヤ |
| GB0301014D0 (en) * | 2003-01-16 | 2003-02-19 | Biocompatibles Ltd | Conjugation reactions |
| EP1590388A2 (en) | 2003-02-05 | 2005-11-02 | Biocompatibles UK Limited | Block copolymers |
| DE602004029319D1 (de) * | 2003-02-18 | 2010-11-11 | Univ Tokai | Verbindung mit phoshorylcholingruppe, dessen polymer und verfahren zu dessen herstellung |
| JP4718766B2 (ja) * | 2003-06-03 | 2011-07-06 | テルモ株式会社 | 血液フィルター |
| US7648833B2 (en) * | 2003-06-25 | 2010-01-19 | Nof Corporation | Container for germ layer formation and method of forming germ layer |
| WO2005027991A1 (en) * | 2003-09-19 | 2005-03-31 | Cambridge University Technical Services Ltd | Orthopaedic devices |
| US8801692B2 (en) * | 2003-09-24 | 2014-08-12 | Medtronic Vascular, Inc. | Gradient coated stent and method of fabrication |
| JP4248366B2 (ja) * | 2003-10-21 | 2009-04-02 | ポーラ化成工業株式会社 | 敏感肌用のメークアップ |
| RU2354409C2 (ru) * | 2003-11-07 | 2009-05-10 | Нобиль Био Ричерке С.Р.Л. | Способ производства высвобождающих лекарственные средства медицинских устройств и полученное с его применением устройство |
| WO2006008739A2 (en) * | 2004-07-19 | 2006-01-26 | Elutex Ltd. | Modified conductive surfaces having active substances attached thereto |
| FR2884142A1 (fr) * | 2005-04-06 | 2006-10-13 | Oreal | Polymeres ou copolymeres de type polyolefinique modifies utiles en cosmetique |
| EP1885476B1 (en) * | 2005-05-25 | 2015-07-08 | Gore Enterprise Holdings, Inc. | Multi-functional coatings on microporous substrates |
| CA2623565A1 (en) | 2005-09-28 | 2007-04-05 | Biovascular, Inc. | Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation |
| FR2892939B1 (fr) * | 2005-11-10 | 2010-01-22 | Groupement Coeur Artificiel Total Carpentier Matra Carmat | Materiau hemocompatible composite et son procede d'obtention |
| US20070129690A1 (en) | 2005-12-02 | 2007-06-07 | Joel Rosenblatt | Catheter with polymeric coating |
| US7906134B2 (en) | 2005-12-21 | 2011-03-15 | Abbott Laboratories | Room temperature-curable polymers |
| RU2421477C2 (ru) * | 2006-04-17 | 2011-06-20 | Асахи Касеи Кемикалз Корпорейшн | СПОСОБ ПОЛУЧЕНИЯ α-МЕТИЛСТИРОЛА И СПОСОБ ПОЛУЧЕНИЯ ТЕРМОСТОЙКОГО СОПОЛИМЕРА НА ОСНОВЕ СТИРОЛА С ИСПОЛЬЗОВАНИЕМ α-МЕТИЛСТИРОЛА |
| EP2716307B1 (en) | 2006-06-13 | 2022-08-03 | Alchimedics | Drug eluting stent with a biodegradable release layer attached with an electro-grafted primer coating |
| WO2008006912A2 (en) | 2006-07-14 | 2008-01-17 | Biocompatibles Uk Limited | Polymer |
| US8372399B2 (en) | 2006-08-31 | 2013-02-12 | Cardiac Pacemakers, Inc. | Bispecific antibodies and agents to enhance stem cell homing |
| US8636995B2 (en) | 2006-08-31 | 2014-01-28 | Cardiac Pacemakers, Inc. | Methods and devices to regulate stem cell homing |
| EP1911791A1 (en) * | 2006-10-03 | 2008-04-16 | Institut Curie | Method for treating surfaces containing Si-H groups |
| US7713541B1 (en) * | 2006-11-21 | 2010-05-11 | Abbott Cardiovascular Systems Inc. | Zwitterionic terpolymers, method of making and use on medical devices |
| DE602007003186D1 (de) * | 2007-03-21 | 2009-12-24 | Du Pont | Fluorobetain-copolymer und Löschschaumkonzentrate daraus |
| GB0706783D0 (en) * | 2007-04-05 | 2007-05-16 | Systems Medical Ltd | Apparatus for deploying endoscope |
| US20080286332A1 (en) * | 2007-05-14 | 2008-11-20 | Pacetti Stephen D | Implantable medical devices with a topcoat layer of phosphoryl choline acrylate polymer for reduced thrombosis, and improved mechanical properties |
| EP3505142B1 (en) | 2007-10-19 | 2020-10-28 | CeloNova Biosciences, Inc. | Implantable and lumen-supporting stents |
| US7780879B2 (en) * | 2007-12-20 | 2010-08-24 | Novartis Ag | Method for making contact lenses |
| WO2009138472A1 (en) * | 2008-05-15 | 2009-11-19 | Biocompatibles Uk Limited | Amphiphilic block copolymers for nucleic acid delivery |
| EP2144062A1 (en) | 2008-05-15 | 2010-01-13 | Biocompatibles UK Limited | Method of monitoring live cells |
| US8470906B2 (en) * | 2008-09-30 | 2013-06-25 | Johnson & Johnson Vision Care, Inc. | Ionic silicone hydrogels having improved hydrolytic stability |
| WO2010092686A1 (ja) * | 2009-02-16 | 2010-08-19 | 株式会社メニコン | 親水性表面を有する眼用レンズおよび眼用レンズの製造方法 |
| WO2011075185A1 (en) * | 2009-12-18 | 2011-06-23 | Oligasis | Targeted drug phosphorylcholine polymer conjugates |
| US8660628B2 (en) * | 2009-12-21 | 2014-02-25 | Medtronic Minimed, Inc. | Analyte sensors comprising blended membrane compositions and methods for making and using them |
| US20110182964A1 (en) * | 2010-01-22 | 2011-07-28 | Medtronic, Inc. | Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular Disease |
| JP5784008B2 (ja) * | 2010-03-31 | 2015-09-24 | 旭化成メディカル株式会社 | リガンド固定化用基材及びその製造方法 |
| CN102834421B (zh) | 2010-03-31 | 2014-09-24 | Dic株式会社 | 含氟固化性树脂及使用其的活性能量线固化性组合物 |
| US8480227B2 (en) | 2010-07-30 | 2013-07-09 | Novartis Ag | Silicone hydrogel lenses with water-rich surfaces |
| US20130030406A1 (en) | 2011-07-26 | 2013-01-31 | Medtronic Vascular, Inc. | Textured Dilatation Balloon and Methods |
| SG11201400287XA (en) * | 2011-09-01 | 2014-03-28 | Vertellus Specialties Inc | Methods for producing biocompatible materials |
| US9006305B2 (en) | 2011-09-01 | 2015-04-14 | Vertellus Specialties Inc. | Biocompatible material |
| JP5784132B2 (ja) * | 2011-09-28 | 2015-09-24 | 旭化成株式会社 | リガンド固定化用基材及びその製造方法、特異的細胞分離材並びに血液処理器 |
| HUE029018T2 (en) | 2011-10-12 | 2017-02-28 | Novartis Ag | A method for producing UV absorbing contact lenses by coating |
| GB201119363D0 (en) * | 2011-11-10 | 2011-12-21 | Vertellus Specialities Inc | Polymerisable material |
| CA2859195C (en) | 2011-12-14 | 2016-09-27 | Semprus Biosciences Corp. | Imbibing process for contact lens surface modification |
| CA2858730C (en) | 2011-12-14 | 2017-07-18 | Semprus Biosciences Corp. | Surface modified contact lenses |
| US9000063B2 (en) | 2011-12-14 | 2015-04-07 | Semprus Biosciences Corporation | Multistep UV process to create surface modified contact lenses |
| WO2013090790A1 (en) | 2011-12-14 | 2013-06-20 | Semprus Biosciences Corp. | Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants |
| US9120119B2 (en) | 2011-12-14 | 2015-09-01 | Semprus Biosciences Corporation | Redox processes for contact lens modification |
| EP3208283B1 (en) * | 2012-04-26 | 2020-07-29 | Minebea Co., Ltd. | Ultraviolet curable resin composition, sliding member, and method for producing sliding member |
| AU2013274199B2 (en) | 2012-06-14 | 2016-08-11 | Microvention, Inc. | Polymeric treatment compositions |
| WO2014062696A1 (en) | 2012-10-15 | 2014-04-24 | Microvention, Inc. | Polymeric treatment compositions |
| JP6111052B2 (ja) * | 2012-11-22 | 2017-04-05 | 国立大学法人 東京大学 | 耐汚染性を付与するための水溶性表面処理剤、および表面処理方法 |
| HUE031702T2 (en) | 2012-12-17 | 2017-07-28 | Novartis Ag | A method for producing improved UV absorbing ophthalmic lenses |
| US10597540B2 (en) * | 2013-05-27 | 2020-03-24 | Jsr Corporation | Surface treatment agent for surface configured from inorganic material, tool and device having modified surface, and method for manufacturing tool and device |
| CA2914618A1 (en) * | 2013-06-07 | 2014-12-11 | Nissan Chemical Industries, Ltd. | Cell culture vessel |
| JP2015061901A (ja) * | 2013-08-21 | 2015-04-02 | 学校法人東海大学 | ホスホリルコリン基を有する重合体からなるナノシート分散液 |
| WO2015035342A2 (en) | 2013-09-08 | 2015-03-12 | Oligasis Llc | Factor viii zwitterionic polymer conjugates |
| US9517952B2 (en) | 2013-11-15 | 2016-12-13 | General Electric Company | Hydrophilic-oleophobic copolymer composition and uses thereof |
| HUE038809T2 (hu) | 2013-12-17 | 2018-11-28 | Novartis Ag | Térhálósított hidrofíl bevonattal ellátott szilikon hidrogél lencse |
| US10351648B2 (en) * | 2014-07-25 | 2019-07-16 | Akzo Nobel Coatings International B.V. | Method of preparing a zwitterionic copolymer |
| MY183678A (en) | 2014-08-26 | 2021-03-08 | Alcon Inc | Method for applying stable coating on silicone hydrogel contact lenses |
| CN105237790B (zh) * | 2015-11-16 | 2018-02-09 | 西安科技大学 | 一种双仿生涂层的制备方法 |
| KR102604468B1 (ko) | 2015-12-15 | 2023-11-22 | 알콘 인코포레이티드 | 실리콘 하이드로겔 콘택트 렌즈 상에 안정한 코팅을 적용하기 위한 방법 |
| GB201603296D0 (en) | 2016-02-25 | 2016-04-13 | Ucl Business Plc | Chemotactic,drug-containing polymersomes |
| CN105504328B (zh) * | 2016-02-25 | 2018-06-29 | 西安科技大学 | 一种室温下一步涂覆改善壳聚糖膜血液相容性的方法 |
| GB201604553D0 (en) | 2016-03-17 | 2016-05-04 | Ucl Business Plc | Fumarate polymersomes |
| JP6705685B2 (ja) * | 2016-03-31 | 2020-06-03 | 旭化成メディカル株式会社 | 生体由来液処理フィルター及びフィルターデバイス |
| GB201608737D0 (en) | 2016-05-18 | 2016-06-29 | Ucl Business Plc | Polymersomes |
| JP6911852B2 (ja) | 2016-06-15 | 2021-07-28 | 日産化学株式会社 | 凍結保存用容器 |
| US10368874B2 (en) | 2016-08-26 | 2019-08-06 | Microvention, Inc. | Embolic compositions |
| JP6944244B2 (ja) * | 2016-12-13 | 2021-10-06 | 三菱マテリアル電子化成株式会社 | 含フッ素重合性化合物、含フッ素重合体、および表面処理剤 |
| TWI640557B (zh) * | 2017-07-05 | 2018-11-11 | 晶碩光學股份有限公司 | 具表面修飾的隱形眼鏡及其製備方法 |
| TW201923065A (zh) | 2017-09-26 | 2019-06-16 | 日商日產化學股份有限公司 | 具有微小容積之細胞培養容器 |
| JP7362598B2 (ja) | 2017-10-09 | 2023-10-17 | マイクロベンション インコーポレイテッド | 放射性液体塞栓物質 |
| CN117492228A (zh) | 2017-12-13 | 2024-02-02 | 爱尔康公司 | 周抛和月抛水梯度接触镜片 |
| GB201806095D0 (en) | 2018-04-13 | 2018-05-30 | Ucl Business Plc | Metabolisable pH sensitive polymersomes |
| GB201810788D0 (en) | 2018-06-29 | 2018-08-15 | Biocompatibles Uk Ltd | Biodegradable polymer |
| TW202000189A (zh) | 2018-06-29 | 2020-01-01 | 英商白康帝英國有限公司 | 不透射線聚合物 |
| CN113646003A (zh) | 2019-01-07 | 2021-11-12 | Ucl商业有限公司 | 多配体官能化的聚合物泡囊 |
| TW202100679A (zh) * | 2019-02-12 | 2021-01-01 | 日商日產化學股份有限公司 | 具有對生物物質之相容性的聚合物之製造方法 |
| WO2020213524A1 (ja) | 2019-04-15 | 2020-10-22 | 日油株式会社 | ホスホリルコリン基含有ビニル系単量体 |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| JP7425405B2 (ja) * | 2020-03-13 | 2024-01-31 | 日油株式会社 | 共重合体およびその用途 |
| WO2022135878A1 (de) | 2020-12-22 | 2022-06-30 | Acandis Gmbh | Intravaskuläres implantat und herstellungsverfahren |
| DE102021106472A1 (de) | 2020-12-22 | 2022-06-23 | Acandis Gmbh | Intravaskuläres Implantat und Herstellungsverfahren |
| WO2022144810A1 (en) | 2020-12-29 | 2022-07-07 | Sino Medical Sciences Technology Inc. | Drug eluting stent |
| CN113336795A (zh) * | 2021-06-02 | 2021-09-03 | 中国科学院长春应用化学研究所 | 胆碱磷酸单体及其聚合物以及应用 |
| KR20240104128A (ko) * | 2021-11-02 | 2024-07-04 | 닛산 가가쿠 가부시키가이샤 | 생체 물질 부착 억제재 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02101964A (ja) * | 1988-10-06 | 1990-04-13 | Fujitsu Denso Ltd | スナバ回路 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3671502A (en) * | 1970-11-12 | 1972-06-20 | Kendall & Co | Betaine copolymers with hydroxyalkylacrylates and hydroxyalkylmethacrylates |
| AU494547B2 (en) * | 1972-07-10 | 1977-10-20 | Johnson & Johnson | Hydrophilic random interpolymer compositions and method for making same |
| JPS53282A (en) * | 1976-06-24 | 1978-01-05 | Nippon Paint Co Ltd | Thermosetting resin, method of preparing same, and coating composition containing same as main component |
| DE3010185A1 (de) * | 1980-03-17 | 1981-09-24 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Polymerisierbare phospholipide, verfahren zu ihrer herstellung und ihre verwendung zur herstellung polymerer phospholipide |
| US5002582A (en) * | 1982-09-29 | 1991-03-26 | Bio-Metric Systems, Inc. | Preparation of polymeric surfaces via covalently attaching polymers |
| JPS6021599A (ja) * | 1983-07-15 | 1985-02-02 | 松下電工株式会社 | 多層配線基板の製造方法 |
| JPS6067489A (ja) * | 1983-09-22 | 1985-04-17 | Toyo Soda Mfg Co Ltd | 重合性リン脂質の製造法 |
| JPS60179408A (ja) * | 1984-02-24 | 1985-09-13 | Oki Electric Ind Co Ltd | リン脂質類似構造を有する化合物及びポリマ−並びにその製造方法 |
| JPS60204711A (ja) * | 1984-03-30 | 1985-10-16 | Mitsubishi Chem Ind Ltd | 薬理活性物質の徐放方法 |
| US4569858A (en) * | 1985-01-28 | 1986-02-11 | Barnes-Hind, Inc. | Surface modification of hydrophilic contact lenses |
| JPS61205291A (ja) * | 1985-03-09 | 1986-09-11 | Mitsubishi Chem Ind Ltd | 2個の重合活性基を有するリン脂質類似モノマ−およびその製造方法 |
| US4737295A (en) * | 1986-07-21 | 1988-04-12 | Venture Chemicals, Inc. | Organophilic polyphenolic acid adducts |
| US5045593A (en) * | 1986-07-21 | 1991-09-03 | Venture Chemicals, Inc. | Organophilic modified polymers |
| US4778865A (en) * | 1986-12-11 | 1988-10-18 | National Starch And Chemical Corporation | Alpha-aminomethylene phosphonate betaines and polymers prepared therewith |
| JPS63221184A (ja) * | 1987-03-11 | 1988-09-14 | Oki Electric Ind Co Ltd | 累積膜及び累積重合膜並びにそれらの製造方法 |
| CA1314353C (en) * | 1987-05-14 | 1993-03-09 | Donald L. Schmidt | Fluorocarbon containing, reactive polymeric surfactants and coating compositions therefrom |
| JP2890316B2 (ja) * | 1989-07-07 | 1999-05-10 | 科学技術振興事業団 | 生体適合性医療デバイス用材料 |
| US5026490A (en) * | 1990-08-08 | 1991-06-25 | Exxon Research & Engineering | Zwitterionic functionalized polymers as deflocculants in water based drilling fluids |
| US5270415A (en) * | 1990-12-21 | 1993-12-14 | Allergan Inc. | Balanced charge polymer and hydrophilic contact lens manufactured therefrom |
| GB9113875D0 (en) * | 1991-06-27 | 1991-08-14 | Biointeractions Ltd | Polymer coatings |
| WO1993001221A1 (en) | 1991-07-05 | 1993-01-21 | Biocompatibles Limited | Polymeric surface coatings |
| SG54134A1 (en) * | 1991-10-14 | 1998-11-16 | Nof Corp | Treating solution for contact lenses |
| US5208295A (en) * | 1991-11-25 | 1993-05-04 | Isp Investments Inc. | Charge imbalanced polyelectrolyte composition |
| US5223580A (en) * | 1992-03-16 | 1993-06-29 | Isp Investments Inc. | Process for making a charge imbalanced polymer |
| US5492989A (en) * | 1992-03-16 | 1996-02-20 | Isp Investments Inc. | Charge imbalanced polyelectrolyte composition |
-
1992
- 1992-07-06 WO PCT/GB1992/001215 patent/WO1993001221A1/en not_active Ceased
- 1992-07-06 RU RU93058558/04A patent/RU2167886C2/ru active
- 1992-07-06 EP EP92914110A patent/EP0593561B1/en not_active Expired - Lifetime
- 1992-07-06 CA CA002277953A patent/CA2277953C/en not_active Expired - Lifetime
- 1992-07-06 AT AT92914110T patent/ATE190988T1/de not_active IP Right Cessation
- 1992-07-06 DE DE69230823T patent/DE69230823T2/de not_active Expired - Lifetime
- 1992-07-06 US US08/175,348 patent/US5648442A/en not_active Expired - Lifetime
- 1992-07-06 JP JP5502087A patent/JP3030086B2/ja not_active Expired - Lifetime
- 1992-07-06 CA CA002112411A patent/CA2112411C/en not_active Expired - Lifetime
- 1992-07-06 AU AU22310/92A patent/AU666485B2/en not_active Expired
- 1992-07-06 ES ES92914110T patent/ES2144419T3/es not_active Expired - Lifetime
- 1992-07-06 DK DK92914110T patent/DK0593561T3/da active
- 1992-07-06 CA CA002313676A patent/CA2313676C/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/478,651 patent/US5783650A/en not_active Expired - Lifetime
-
1998
- 1998-07-08 JP JP20868798A patent/JP3190620B2/ja not_active Expired - Fee Related
- 1998-07-08 JP JP20870198A patent/JP3233902B2/ja not_active Expired - Lifetime
- 1998-07-08 JP JP20708498A patent/JP3315367B2/ja not_active Expired - Fee Related
-
1999
- 1999-12-07 JP JP34809899A patent/JP3204956B2/ja not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02101964A (ja) * | 1988-10-06 | 1990-04-13 | Fujitsu Denso Ltd | スナバ回路 |
Cited By (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11166015A (ja) * | 1991-07-05 | 1999-06-22 | Biocompatibles Ltd | 表面を生物および血液適合性にするために有用なポリマー |
| JPH11166018A (ja) * | 1991-07-05 | 1999-06-22 | Biocompatibles Ltd | 表面を生物および血液適合性にするために有用なポリマー |
| JP2006124714A (ja) * | 1992-09-29 | 2006-05-18 | Toray Ind Inc | 耐汚染性材料および耐汚染性半透膜 |
| JPH07268038A (ja) * | 1994-03-31 | 1995-10-17 | Nippon Oil & Fats Co Ltd | ホスホリルコリン基又はその誘導体基含有共重合体、その製造法及び抗血栓性材料 |
| JPH08333421A (ja) * | 1995-04-03 | 1996-12-17 | Nippon Oil & Fats Co Ltd | ホスホリルコリン基含有重合体水性溶液および製造方法 |
| JP2001504877A (ja) * | 1996-11-20 | 2001-04-10 | バイオコンパテイブルズ・リミテツド | 生体適合性の組成物 |
| JPH11322857A (ja) * | 1998-05-08 | 1999-11-26 | Nof Corp | 静電結合型高分子複合体および製造方法 |
| JP2002520463A (ja) * | 1998-07-17 | 2002-07-09 | バイオコンパテイブルズ・リミテツド | コートされた成形ポリマー物品の提供方法 |
| JP2002524628A (ja) * | 1998-09-15 | 2002-08-06 | ノバルティス アクチエンゲゼルシャフト | ポリマー |
| JP2000162556A (ja) * | 1998-09-21 | 2000-06-16 | Menicon Co Ltd | 眼用レンズ材料およびその製法 |
| JP2002530456A (ja) * | 1998-11-13 | 2002-09-17 | バイオコンパテイブルズ・リミテツド | 両性イオン性モノマー成分を含んでなるアニオン性−カチオン性ポリイオンコンプレックス |
| JP2003503157A (ja) * | 1999-05-27 | 2003-01-28 | バイオコンパテイブルズ・リミテツド | 局所的な薬剤送達 |
| JP2003506501A (ja) * | 1999-05-27 | 2003-02-18 | バイオコンパテイブルズ・リミテツド | ポリマー溶液 |
| JP2004500458A (ja) * | 2000-02-07 | 2004-01-08 | バイオコンパティブルズ ユーケー リミテッド | モノマー及びマクロマーとして有用なマイケル型反応からの化合物を含む両性イオン基 |
| JP2004196868A (ja) * | 2002-12-16 | 2004-07-15 | Nof Corp | ポリマーナノスフェア、その用途及び製造方法 |
| US7713520B2 (en) | 2004-03-31 | 2010-05-11 | Shin-Etsu Chemical Co., Ltd. | Cosmetic comprising a silicone polymer |
| WO2007116690A1 (ja) | 2006-03-29 | 2007-10-18 | Japan Medical Materials Corporation | 生体材料、及びそれを用いた人工関節並びにその製造方法 |
| JP2010024257A (ja) * | 2008-07-15 | 2010-02-04 | Fujifilm Corp | 生体適合性重合性化合物、生体適合性ポリマー、及び、ポリマー粒子 |
| US9809717B2 (en) | 2010-05-25 | 2017-11-07 | 3M Innovative Properties Company | Antimicrobial-coated medical articles |
| JP2013529118A (ja) * | 2010-05-25 | 2013-07-18 | スリーエム イノベイティブ プロパティズ カンパニー | 抗菌剤コーティングされた医療用物品 |
| JP2016514750A (ja) * | 2013-03-25 | 2016-05-23 | ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピックSociete D’Exploitation De Produits Pour Les Industries Chimiques Seppic | 新規な両親媒性ポリマー及び疎水性材料から作られている表面の処理におけるその使用 |
| JP2015084848A (ja) * | 2013-10-29 | 2015-05-07 | 株式会社八光 | 医療用樹脂成形物へのコーティング方法 |
| JP2015117269A (ja) * | 2013-12-17 | 2015-06-25 | 日油株式会社 | ポリマー及びその製造方法 |
| CN106794290A (zh) * | 2014-10-02 | 2017-05-31 | 旭化成医疗株式会社 | 源自生物体的液体处理过滤器及过滤器装置 |
| WO2016158700A1 (ja) * | 2015-03-30 | 2016-10-06 | テルモ株式会社 | 医療用具 |
| JP2017190381A (ja) * | 2016-04-12 | 2017-10-19 | 花王株式会社 | 表面処理剤 |
| JP2019210363A (ja) * | 2018-06-04 | 2019-12-12 | 信越化学工業株式会社 | ポリシロキサンモノマー及びその製造方法 |
| WO2019235390A1 (ja) * | 2018-06-04 | 2019-12-12 | 信越化学工業株式会社 | ポリシロキサンモノマー及びその製造方法 |
| US11859055B2 (en) | 2018-06-04 | 2024-01-02 | Shin-Etsu Chemical Co., Ltd. | Polysiloxane monomer and method for producing same |
| JP2020063318A (ja) * | 2018-10-15 | 2020-04-23 | 千秋 東 | ホスホリルコリン基含有共重合体、および生体用医療基材 |
| WO2021070862A1 (ja) * | 2019-10-09 | 2021-04-15 | 日油株式会社 | ソフトコンタクトレンズ用表面処理剤 |
| JPWO2021070862A1 (ja) * | 2019-10-09 | 2021-04-15 | ||
| US12384934B2 (en) | 2019-10-09 | 2025-08-12 | Nof Corporation | Surface treatment agent for soft contact lens |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2313676C (en) | 2006-10-10 |
| JP3315367B2 (ja) | 2002-08-19 |
| DK0593561T3 (da) | 2000-08-21 |
| CA2112411A1 (en) | 1993-01-21 |
| ATE190988T1 (de) | 2000-04-15 |
| JP2000226550A (ja) | 2000-08-15 |
| CA2277953C (en) | 2001-01-16 |
| AU666485B2 (en) | 1996-02-15 |
| AU2231092A (en) | 1993-02-11 |
| EP0593561A1 (en) | 1994-04-27 |
| RU2167886C2 (ru) | 2001-05-27 |
| JP3030086B2 (ja) | 2000-04-10 |
| US5783650A (en) | 1998-07-21 |
| JP3233902B2 (ja) | 2001-12-04 |
| EP0593561B1 (en) | 2000-03-22 |
| JP3204956B2 (ja) | 2001-09-04 |
| JP3190620B2 (ja) | 2001-07-23 |
| DE69230823T2 (de) | 2000-07-27 |
| JPH11166018A (ja) | 1999-06-22 |
| JPH11166015A (ja) | 1999-06-22 |
| CA2112411C (en) | 2001-01-02 |
| JPH11166150A (ja) | 1999-06-22 |
| US5648442A (en) | 1997-07-15 |
| WO1993001221A1 (en) | 1993-01-21 |
| CA2313676A1 (en) | 1993-01-21 |
| ES2144419T3 (es) | 2000-06-16 |
| DE69230823D1 (de) | 2000-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH07502053A (ja) | ポリマーの表面コーティング | |
| US5705583A (en) | Polymeric surface coatings | |
| US5739236A (en) | Biocompatible zwitterion polymers | |
| US6284854B1 (en) | Polymeric surface coatings | |
| US6090901A (en) | Polymeric surface coatings | |
| US6087462A (en) | Polymeric surface coatings | |
| US7160953B2 (en) | Polymeric surface coatings | |
| JP3957741B2 (ja) | 双性イオン基を有する高分子配合物 | |
| US6225431B1 (en) | Biocompatibilizing process | |
| EP0810239B1 (en) | Polymeric surface coatings | |
| JPH09504561A (ja) | ポリマーの表面コーティング材 | |
| EP0556216B1 (en) | Phosphoric acid esters and their use in the preparation of biocompatible surfaces | |
| EP0818479B1 (en) | Polymeric surface coatings | |
| AU697066B2 (en) | Polymeric surface coatings | |
| AU728822B2 (en) | Polymeric surface coatings |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080204 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090204 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100204 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100204 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110204 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120204 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120204 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130204 Year of fee payment: 13 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130204 Year of fee payment: 13 |